Dr. Chin is Executive VP for Translational Medical Science and former Chief Medical Office (CMO) of Frequency Therapeutics and Bertarelli Professor of Translational Medical Science and Professor of Medicine Emeritus at Harvard Medical School (HMS). He is formerly Executive Vice President for Science and Regulatory Advocacy and CMO at Pharmaceutical Research and Manufacturers of America (PhRMA) where he led PhRMA’s continuing efforts in science and regulatory advocacy in the drug discovery and development ecosystem. Prior to PhRMA, he was the Executive Dean for Research at HMS. Before that, he was at Eli Lilly and Company last as Senior Vice President for Discovery Research and Clinical Investigation.

Dr. Chin is a Harvard-trained endocrinologist and longstanding faculty member. His career is highlighted by leadership in molecular endocrinology and translational science and medicine during his 25 years on the Harvard Medical School faculty. During this time, Bill was Chief of the Genetics Division in the Department of Medicine at Brigham and Women’s Hospital, a Howard Hughes Medical Institute Investigator and Professor of Medicine at HMS. He has been honored with numerous awards for research, mentorship and leadership. He is a past president of the Harvard Medical Alumni Association. Bill received his A.B. in Chemistry from Columbia University and his M.D. from Harvard Medical School.